Antiretroviral News and Research

RSS

How HIV/AIDS treatment can best be combined with community-based care in some of the poorest areas of sub-Saharan Africa

A West African community has joined the network of community-based treatment support programs that form Bristol-Myers Squibb's real world field test of how HIV/AIDS treatment can best be combined with community-based care in some of the poorest and most remote areas of sub-Saharan Africa.

13 Jul 2004

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).

12 Jul 2004

HIV patients treated with antiretroviral therapy early after infection do test negative

UCSF researchers have found that some HIV patients treated with antiretroviral therapy early after infection do test negative, at some point, for the virus. Study findings showed this result in six of 87 patients.

12 Jul 2004

Increasing levels of growth hormone may be an effective treatment for HIV lipodystrophy

Increasing the body's production of growth hormone may be an effective treatment for HIV lipodystrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection.

11 Jul 2004

Average cost for providing primary care to an HIV-infected patient is $30 USD per visit

Researchers at Johns Hopkins and University of Witwatersrand, South Africa, have determined that the actual average cost for providing primary care to an HIV-infected patient is $30 USD per visit.

11 Jul 2004

Widespread prenatal HIV screening and use of antiretroviral drugs in pregnant HIV-infected women is needed

Rapid testing during labor can enable pregnant women with undocumented HIV status to learn their HIV infection status so they can receive antiretroviral prophylaxis and be referred for comprehensive medical care and follow-up according to a report in the current issue of the Journal of the American Medical Association.

11 Jul 2004

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Results from a three year double-blinded trial which compared antiretroviral therapies show that the combination regimens of tenofovir DF and stavudine, are equally effective, though tenofovir DF has more favorable outcomes with respect to cholesterol levels and the nervous system.

11 Jul 2004

Nevirapine effective in reducing the risk of transmission of HIV at birth

A drug called nevirapine has been shown to be effective in reducing the risk of transmission of HIV at birth, but combination therapy of nevirapine and zidovudine does not improve outcomes, according to a study published in the current HIV/AIDS Journal of the American Medical Association.

11 Jul 2004

Cheap AIDS drugs may help prevent HIV in babies in Thailand

Aids is one of the principal causes of infant mortality in many developing countries. Viral transmission takes place during pregnancy (in utero), at the moment of childbirth or even during breastfeeding.

10 Jul 2004

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

The development of simple and inexpensive generic fixed-dose combined therapies appears the most suitable solution for making possible this access to treatments in developing countries with meagre resources.

3 Jul 2004

Americans give Russia $34.2 million to help treat and care for people living with HIV/AIDS and tuberculosis

HHS Secretary Tommy G. Thompson announced today that the Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Russia $34.2 million over two years to help treat and care for people living with HIV/AIDS and tuberculosis.

2 Jul 2004

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.

2 Jul 2004

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

One of the strategies adopted consists in utilizing combinations of fixed doses of generic antiretrovirals, involving three medicinal drugs of two different classes in the same tablet.

2 Jul 2004

Women delay AIDS with vitamins B, C and E

Daily intake of multivitamins appears to delay the progress of the AIDS virus according to the results of a study of HIV infected women in Tanzania by Harvard researchers.

30 Jun 2004

Bush outlines government actions on HIV/AIDS

President Bush visited Philadelphia, Pennsylvania last week, to discuss the need for providing treatment to Americans living with HIV/AIDS, and to highlight the work of faith-based and community organizations as they seek to treat and care for Americans living with HIV/AIDS.

26 Jun 2004

Antiretroviral News and Research

How HIV/AIDS treatment can best be combined with community-based care in some of the poorest areas of sub-Saharan Africa

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

HIV patients treated with antiretroviral therapy early after infection do test negative

Increasing levels of growth hormone may be an effective treatment for HIV lipodystrophy

Average cost for providing primary care to an HIV-infected patient is $30 USD per visit

Widespread prenatal HIV screening and use of antiretroviral drugs in pregnant HIV-infected women is needed

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Nevirapine effective in reducing the risk of transmission of HIV at birth

Cheap AIDS drugs may help prevent HIV in babies in Thailand

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Americans give Russia $34.2 million to help treat and care for people living with HIV/AIDS and tuberculosis

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

Women delay AIDS with vitamins B, C and E

Bush outlines government actions on HIV/AIDS

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Treatment of cytomegalovirus remains a priority in order to improve the prognosis for people with HIV-1 infection

2000 Ukrainian patients to receive treatment for HIV/AIDS

WHO removes two antiretroviral products from the WHO List of prequalified products

Harmless virus known as GBV-C slows the progression of HIV

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News